Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Most recent
Best match
Daily
20m
USFDA approves Bristol Myers Squibb Cobenfy for Schizophrenia treatment in adults
Princeton: Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) has approved COBENFY ...
26m
Stock indexes drift to end of record-setting week
All told, the S&P 500 slipped 7.20 points to 5,738.17, but it still closed out a third straight winning week and its sixth in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
'Harry Potter' star dies
Helene: How to help
High-end brothel plea
Troops to leave some bases
Promotes watch collection
ICE: Convicts roaming free
Congressional Gold Medal
Dow closes at record high
Killer gets life sentence
Boxes to distribute Narcan
World's oldest cheese found
Ending password-sharing
Fake Biden robocalls fine
Producing doc on Diddy
50/50 ball ownership suit
Urgent safety alert for 737s
Meta hit with privacy fine
ISR targets Hezbollah HQ
Diocese reaches settlement
Van Gogh paintings attacked
Pleads not guilty
US charges three Iranians
NC dam failure ‘imminent’
Bill to use birth control
Fed inflation gauge cools
NY ballot appeal rejected
KY sues Express Scripts
Deposition in AI suit
Related topics
Food and Drug Administration
KarXT
Cobenfy
Feedback